logo-loader

SkinBioTherapeutics raise £4m to expand SkinBiotix technology in oral and healthcare

Published: 10:34 14 Oct 2020 BST

Skinbiotherapeutics Plc's (LON:SBTX) Doug Quinn talks to Proactive's Katie Pilbeam on their plans for the £4m raised from existing and new institutions to fund work on new product applications.

Quinn explains how they plan to expand skin biotics technology into oral and healthcare as well as establish a 'physical footprint of a lab'.

The funds will also be invested to expand the group’s research capabilities by adding its own facilities to those it uses at the University of Manchester.

Cordiant Digital Infrastructure marks three years of strategic growth and...

Cordiant Digital Infrastructure Ltd (LSE:CORD) Chairman of Digital Infrastructure Steven Marshall and Chief Financial Officer Mark Tiner joined Steve Darling from Proactive to provide some insight on the company’s three-year anniversary since listing on the London Stock Market. The company...

1 hour, 6 minutes ago